baber/WOPTO huggingface dataset:
Patent CA-2719436-A1 (CA)
Inventor: WEI GAN
IPC: F21K99/00
Filed: 2010-10-27
Abstract: An auto hammer includes a housing, a head assembly arranged on one end of the housing, a battery pack mounted at the other end of the housing, and a motor contained in the housing. The housing further includes a grip portion, where the gravity center of the auto hammer lies. The auto hammer is thereby more ergonomic so that the users feel more comfortable when holding the auto hammer and spend less effort during its operation.
Patent CA-2719673-A1 (CA)
Inventor: BAE MYUNG M
IPC: G06F15/16
Filed: 2010-11-05
Abstract: An illustrative embodiment of a computer-implemented process for fencing shared cluster resources in event of a possible split-brain, identifies a failing resource of a node within a set of shared resources to form an identified failing resource, fences a subset of the set of shared resources to form a winning subset of shared resources and prevents the identified failing resource from communicating with the winning subset of shared resources using a white list maintained at each database system of the winning subset of shared resources. The computer-implemented process further determines whether the identified failing resource has been cleared to form a cleared failing resource and responsive to a determination that the identified failing resource has been cleared, rejoins the cleared failing resource with the winning subset of the set of shared resources absent a re-boot of the cleared failing resource.
Patent CA-2720666-A1 (CA)
Title: Powder formed from mineral or rock material with controlled particle size distribution for thermal films
Inventor: KRAGTEN DAVID D
IPC: B07B13/04
Filed: 2008-09-25
Abstract: An ultra-fine powder formed from a naturally occurring mineral or rock material and having a controlled or 'engineered' particle size distribution (PSD) to match the infrared spectra with a maximum particle size in the range of 14-17 microns measured as either D99, or preferably D95, and a minimum particle size D5 in the range of 4-7 microns. Preferably the maximum particle size is about 15 microns, the minimum particle size is about 5 microns and the D50 particle size is about 8-10 microns with the moisture content of the particle size 'engineered' powder being less than about 0.20 percent by weight and preferably about 0.05 to 0.08 percent by weight of the powder. This specially 'engineered' ultra-fine powder is used to reduce the thermicity of thermal film to a value less than about 20%.
Patent CA-2722040-A1 (CA)
Inventor: TAYLOR EVELYN JEAN
IPC: A01P7/04
Filed: 2009-04-29
Abstract: New pesticidal compositions comprising pyriproxyfen and methyl esters of C16 -Ci18 fatty acids and having low volatile organic compound (VOC) content are provided. Methods of use and ready-to-use products are also provided.
Patent CA-2722051-A1 (CA)
Title: Method and apparatus for variable video bitrate control in which picture bitrate correction is limited to be within a calculated range
Inventor: TANIDA RYUICHI
IPC: H04N19/136
Filed: 2009-06-03
Abstract: Disclosed are a video encoding amount control method and device that control the amount of encoding generated for a picture to be encoded based on the initial value of an encoding amount preassigned for each picture. The difference between the assigned encoding amount and the amount of encoding actually generated by a picture for which encoding is completed is determined as the error encoding amount. Then, for subsequent multiple pictures, based on whether said error encoding amount is positive or negative, either the maximum or minimum value of the assigned encoding amount calculated by using the initial value of the assigned encoding amount and a predetermined constant is selected as the allowed correction width. For said multiple pictures, the difference between said allowed correction width and the assigned encoding amount is determined as the variable encoding amount. The ratio between the sum of said variable encoding amounts and said error encoding amount is determined as the update ratio. For said multiple pictures, the variable encoding amount for the assigned encoding amount is calculated based on said variable encoding amount and said update ratio, and the assigned encoding amount for each of said multiple pictures is updated based on said variable encoding amount.
Patent CA-2722137-A1 (CA)
Inventor: BEBBINGTON CHRISTOPHER R
IPC: A61P11/00
Filed: 2009-04-28
Abstract: The current invention relates to high-affinity antibodies to Granulocyte-Macrophage Colony-Stimulating Factor that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.
Patent CA-2722748-A1 (CA)
Inventor: DE BUHR INGO
IPC: F03D11/04
Filed: 2008-04-30
Abstract: A paneling (30) of a nacelle (12) of a wind energy installation (10), in which an upturned panel ceiling (40) is provided in installation position, is created with a hatch opening (46), that is provided in the panel ceiling (40). The hatch opening (46) is advantageously provided so large, that components of the entire area of a drive train (24) of the wind energy installation (10) can be removed upwards, or inserted from above into the nacelle (12) through the hatch opening (46). Furthermore, such a hatch opening (46) is optionally closable by means of a hatch cover (44).  (See Figure 5)
Patent CA-2726651-A1 (CA)
Title: Dispositif de commande d'appareil(s) mobile(s) autopropulse(s)
Inventor: MOREY EPOUSE PONCELET MICHELE
IPC: G05D1/02
Filed: 2009-05-22
Abstract: L'invention concerne un dispositif de commande d'appareil(s) mobile(s) autopropulsé(s) (300), comportant : une station de base fixe (200), équipée d'un récepteur de système de localisation par satellites, dit récepteur GNSS fixe et d'un émetteur-récepteur radiofréquence adapté pour pouvoir communiquer avec au moins un appareil mobile, et comprenant : un module de positionnement; un module de consignes; et un module de commande adapté pour commander le déplacement de chaque appareil mobile sur le terrain; au moins un appareil mobile (300), comprenant des moyens de déplacement, un récepteur GNSS mobile, et un émetteur-récepteur radiofréquence adapté pour transmettre à la station de base (200) des informations reçues par son récepteur GNSS mobile et recevoir une commande de déplacement.
Patent CA-2731827-A1 (CA)
Inventor: DUKE DEBRA M
IPC: A61K38/19
Filed: 2009-07-22
Abstract: The invention provides for compositions and methods of treating or ameliorating menopausal symptoms and/or symptoms associated with hormonal variations by administering granulocyte colony- stimulating factor (G-CSF). The invention also provides for compositions and methods of treating or ameliorating arthritis using G-CSF.
Patent CA-2732973-A1 (CA)
Inventor: DONG ZHENG XIN
IPC: A61P3/10
Filed: 2009-08-07
Abstract: There is provided a novel series of analogues of glucose-dependent insulinotropic polypeptide compounds, pharmaceutical compositions containing said compounds, and the use of said compounds as GIP-receptor agonists or antagonists for treatment of GIP-receptor mediated conditions, such as non-insulin dependent diabetes mellitus and obesity.
Patent CA-2733712-A1 (CA)
Inventor: CHEN WEI
IPC: F27D1/12
Filed: 2011-03-10
Abstract: A refractory wall comprises a hotface layer comprising a hotface surface configured to be adjacent to a carbonaceous gasification environment, a backing layer facing the hotface layer, and a cooling layer facing the backing layer and configured to cool the hotface layer via the backing layer. A gasification device and a gasification process are also presented.
Patent CA-2734092-A1 (CA)
Inventor: HIRAI SHIGETO
IPC: F03D11/00
Filed: 2009-09-07
Abstract: To provide a wind turbine generator capable of creating an air flow which can efficiently circulate air between the interior of a cover and a nacelle so that the interior of the cover can be efficiently cooled down. A wind turbine generator (1) is provided with a rotor head (4) to which wind turbine blades (6) are attached, a cover (5) which covers the rotor head (4), and a nacelle (3) which accommodates a power generating facility (7) connected to the rotor head (4), and has an air circulation between the interior of the cover (5) and the interior of the nacelle (3), wherein an air flow creation device (20) which creates an air flow is provided inside the cover (5).
Patent CA-2737188-A1 (CA)
Inventor: HILBERER EDUARD
IPC: B60T17/04
Filed: 2009-09-17
Abstract: The invention relates to a parking brake system for a vehicle, comprising an at least partially bistable valve unit to generate a control pressure for controlling at least one function of the parking brake system, and a relay valve which receives the control pressure from the valve unit and either pressurizes or bleeds at least one spring--loaded cylinder according to the control pressure.  According to the invention, the valve unit is integrated into a first module integrated into a compressed air production system, and the relay valve is arranged in a second module which is arranged at a distance from the first module and the compressed air production system.
Patent CA-2737438-A1 (CA)
Inventor: KOLBEL TILO
IPC: A61F2/07
Filed: 2009-10-30
Abstract: A stent graft (18) for deployment in a curved lumen such as the aortic or thoracic arch (130) comprises a constraining mechanism at its proximal end. A stent (4) provided at the proximal end of the stent graft (18) includes loops of material (11) that co-operate with restraining wires (42) that extend between a central guide wire carrier (24) and a restraining wire cannula (8). The constraining mechanism acts to maintain the proximal stent (4') constrained at three points around its circumference at both the proximal and distal ends of the proximal stent (41). The proximal stent (41) is thus allowed to expand after expansion of the remainder of the stent graft (18) during deployment. In an embodiment, the constraining mechanism acts to constrain two adjacent struts of the proximal stent (4') at three points radially therearound, at the proximal end of the stent (41) and at the distal end of the stent (41). The proximal stent (4') may then overlap with the interior of an adjacent stent at an inner part (31) of a curved vessel.
Patent CA-2740479-A1 (CA)
Inventor: CUMMING JOEL GEORGE
IPC: H04W4/029
Filed: 2011-05-18
Abstract: A method of providing location-based advertising to a mobile device entails identifying a frequent path over which the device has repeatedly traveled, identifying an out-of-coverage portion of the frequent path, determining LBA for the out-of-coverage portion of the frequent path, and pre-caching on the mobile device the LBA for the out-of-coverage portion of the frequent path.
Patent CA-2740832-A1 (CA)
Inventor: FOGLE RAYMOND ELBERT III
IPC: C07C51/265
Filed: 2009-10-22
Abstract: The invention provides improved energy content in and shaft power recovery from off-gas from xylene oxidation reactions while at the same time minimizing wastewater treatment cost. More shaft power is produced using off- gas than is required to drive the main air compressor, even with preferred, relatively low oxidation temperatures. Simultaneously, an amount of wastewater greater than byproduct water from oxidation of xylene is kept in vapor form and treated along with off-gas pollutants in a self-sustaining (self-fueling) gas-phase thermal oxidative destruction unit. Optionally, off-gas is combined from multiple xylene oxidation reactors, comprising primary and/or secondary oxidation reactors and forming TPA and/or IPA. Optionally, air compressor condensate and caustic scrubber blowdown are used in a TPA process or as utility water, effectively eliminating normal flow of liquid wastewater effluent from a TPA plant. Optionally, PET off-gas containing the water of PET formation is treated in a shared thermal oxidative destruction unit, effectively eliminating normal flow of liquid wastewater effluent from a combined pX-to-TPA-to-PET plant.
Patent CA-2741050-A1 (CA)
Inventor: LIAO BAISONG
IPC: C12N5/02
Filed: 2009-11-05
Abstract: The invention relates to pharmaceutical compositions for and methods of treatment with HER3-targeted combina-tion therapy. The invention relates to pharmaceutical compositions comprising an oligomer which targets HER3 (and optionally one or more of HER2 and EGFR) mRNA in a cell, leading to reduced expression of HER3 and optionally HER2 and/or EGFR, and a small molecule protein tyrosine kinase inhibitor of one or more receptor tyrosine kinases, leading to inhibition of signaling and/or internalization of receptor dimers into the cell. The combination therapy is beneficial for a range of medical disorders, such hyperproliferative disorders (e.g., cancer). The invention provides methods of treating hyperproliferative disorders with a combi-nation of an oligomer and a protein tyrosine kinase inhibitor.
Patent CA-2741424-A1 (CA)
Title: System for encoding and decoding stereoscopic images
Inventor: CARAMELLI ANTONIO
IPC: H04N13/00
Filed: 2009-09-04
Abstract: A system and a method for encoding and decoding stereoscopic images are described. A stereoscopic image com-prises at least two sub- images arranged according to a first configuration and intended for a user's right eye and left eye, respec-tively. During the video signal post-production stage, a chromatic code is embedded which in adapted to provide information about said configuration. At receiver level, decoding means (14) are used which are adapted to receive said stereoscopic image, recognise the configuration of said at least two sub-images based on information embedded into said stereoscopic image, and ar-range said at least two sub-images according to a second predetermined configuration.
Patent CA-2741548-A1 (CA)
Inventor: RAI GYAN P
IPC: A61K38/00
Filed: 2009-10-23
Abstract: A novel method for de-termining the bioactivity of TGF-.beta. in a sample of milk, raw protein source, or nutritional composition is provided. The method includes particular reconstitution steps, centrifugation steps, incubation steps, and activation steps. The bioactiv-ity of the TGF-.beta. in the sample may be measured in a HT-2 cell bioassay or a cellomics bioassay.
Patent CA-2742078-A1 (CA)
Inventor: MARGARYAN ALFRED A
IPC: C03B11/00
Filed: 2009-10-29
Abstract: Optical components that maintain transparency (remain clear) in high energy environments, including in applications of high-intensity gamma-ray radiation dosage of 1.29 x 10 9 rads and greater, and neutron energy at neutron fluxes ranging from 3x10 9 to 1x10 14 n/cm2 sec and greater, and fluencies ranging from 2x1016 to 8.3x10 20 n/cm2 and greater. Further, the optical components have a bulk laser damage threshold of 105+/-20 J/cm2, a surface laser damage threshold of 72 +/- 15 J/cm2, a Stokes shift of about 9%, and a fractional thermal loading of about 11%.
Patent CA-2744663-A1 (CA)
Inventor: BARAS BENOIT
IPC: A61K39/00
Filed: 2009-12-01
Abstract: The present invention provides an immunogenic composition comprising: an immunogenic SARS coronavirus S  (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising an oil-in-water emulsion.
Patent CA-2745571-A1 (CA)
Title: A prosthetic device and method of manufacturing the same
Inventor: MORTARINO ENRICO
IPC: A61F2/04
Filed: 2009-11-09
Abstract: A biocompatible surgical silk mesh prosthetic device employs a knit pattern that substantially prevents unraveling and preserves the stability of the mesh device, especially when the mesh device is cut. An example prosthetic device employs a knitted mesh including at least two yarns laid in a knit direction and engaging each other to define a plurality of nodes. The at least two yarns include a first yarn and a second yarn extending between and forming loops about two nodes. The second yam has a higher tension at the two nodes than the first yarn. the second yarn substantially prevents the first yarn from moving at the two nodes and substantially prevents the knitted mesh from unraveling at the nodes.
Patent CA-2746244-A1 (CA)
Inventor: DESILETS DAVID J
IPC: A61B10/04
Filed: 2009-11-23
Abstract: A cytology device is described. The cytology scraper (100) comprises a scraping element (110) that provides increased tissue removal capabilities over conventional cytology brushes. The edges (141, 142) of the scraping element can also simultaneously dilate strictures during the tissue removal procedure.
Patent CA-2746699-A1 (CA)
Title: Cellulose based polymer material
Inventor: MELDAL MORTEN
IPC: C08B3/08
Filed: 2009-12-16
Abstract: The invention relates to a polymer material with several advantageous properties. The polymer material has a low degree of swelling in water, it is biodegradable, it has extremely low permeability to gasses such as CO2 and it has a high strength.  The polymer material is useful for a number of purposes, such as for preparing containers for food or beverages. The polymer material is prepared from a prepolymerisation mixture comprising grafted plant derived material and monomers and/or cross-linkers.
Patent CA-2747205-A1 (CA)
Inventor: CONDO PETER D
IPC: B01J21/08
Filed: 2009-12-01
Abstract: Methods of preparing hybrid aerogels are described. The methods include co-condensing a metal oxide precursor and an organo--functional metal oxide precursor, and crosslinking the organo-functional groups with an ethylenically-unsaturated crosslink agent. Thermal ener-gy and actinic radiation crosslinking are described. Both supercritical aerogel and xerogels, including hydrophobic supercritical aerogel and xerogels, are described. Aerogel articles, including flexible aerogel arti-cles are also disclosed.
Patent CA-2747275-A1 (CA)
Inventor: MICKAEL MEDHAT W
IPC: E21B49/00
Filed: 2011-07-26
Abstract: A logging system for measuring anisotrophic properties of the materials penetrated by a borehole. A downhole or "logging tool" element of the system comprises a source section that comprises either a unipole or a dipole acoustic source. The receiver section comprises a plurality of receiver stations disposed at different axial spacings from the acoustic source. Each receiver station comprises one or more acoustic receivers. The system requires that the source and receiver sections rotate synchronously as the logging tool is conveyed along the borehole. Receiver responses are measured in a plurality of azimuthal angle segments and processed as a function of rotation angle of the tool. The logging system can be embodied as a logging-while-drilling system, a measurement-while-drilling system, and a wireline system that synchronously rotates source and receiver sections. All embodiments require that the acoustic source operate at a relatively high frequency.
Patent CA-2747368-A1 (CA)
Inventor: BOSTICK F X III
IPC: G01V8/02
Filed: 2004-09-24
Abstract: The present invention involves methods and apparatus for permanent downhole deployment of optical sensors. Specifically, optical sensors may be permanently deployed within a wellbore using a casing string. In one aspect, one or more optical sensors are disposed on, in, or within the casing string. The optical sensors may be attached to an outer surface of the casing string or to an inner surface of the casing string, as well as embedded within a wall of the casing string. The optical sensors are capable of measuring wellbore parameters during wellbore operations, including completion, production, and intervention operations.
Patent CA-2750386-A1 (CA)
Title: Cnt-infused glass fiber materials and process therefor
Inventor: SHAH TUSHAR K
IPC: B32B9/00
Filed: 2010-02-26
Abstract: A composition includes a carbon nanotube (CNT)-infused glass fiber material, which includes a glass fiber material of spoolable dimensions and carbon nan-otubes (CNTs) bonded to it. The CNTs are uniform in length and distribution. A continuous CNT infusion pro-cess includes: (a) disposing a carbon-nanotube forming catalyst on a surface of a glass fiber material of spoolable dimensions; and (b) synthesizing carbon nanotubes on the glass fiber material, thereby forming a carbon nanotube-in-fused glass fiber material. The continuous CNT infusion process optionally includes extruding a glass fiber material from a glass melt or removing sizing material from a pre-fabricated glass fiber material.
Patent CA-2751174-A1 (CA)
Inventor: MAYER WILLIAM T
IPC: B65D81/38
Filed: 2010-01-28
Abstract: A kit comprising a plurality of separate and distinct identically sized phase change material-containing panels (10) shaped as a frustum of a right pyramid and a method of assembling a thermal insulating enclosure (100) from such panels (10) and the resultant assembled thermal insulting enclosure (100).
Patent CA-2751196-A1 (CA)
Title: Improvements in and relating to posts
Inventor: JAMES DALLAS REX
IPC: E01F9/011
Filed: 2011-09-01
Abstract: The present invention relates to a terminal post for a barrier wherein the post includes: - an upright portion; characterised in that the upright portion has an aperture positioned, so that in use: the aperture is located in a region of the upright portion above a ground engaging portion of the upright portion; and wherein located on one side of the aperture is a transverse reinforcing member which includes a slot for receiving a cable; and wherein there is at least one groove, or pair of notches located beneath the aperture, which form(s) a predetermined fail line, along which the post will deform, upon receiving a substantially inline impact, which causes the transverse member to move so as to release said cable, and wherein the aperture is dimensioned to allow the terminal end of the cable formally retained by the slot to pass therethrough.
Patent CA-2752122-A1 (CA)
Inventor: ZELDIS JEROME B
IPC: A61P27/10
Filed: 2003-05-16
Abstract: Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent CA-2753894-A1 (CA)
Inventor: WANG JOANNE
IPC: C12Q1/37
Filed: 2010-03-12
Abstract: The present specification discloses SNAP-25 immune response inducing compositions, methods of making .alpha.-SNAP-25 antibodies that selectively binds to an epitope comprising a SNAP-25 having a carboxyl-terminus at the P1 residue of the BoNT/A cleavage site scissile bond, .alpha.-SNAP-25 antibodies that selectively bind to an epitope comprising a SNAP-25 having a carboxyl-terminus at the P1 residue of the BoNT/A cleavage site scissile bond, methods of detecting retargeted endopeptidase activity, and methods of detecting neutralizing .alpha.-re-targeted endopeptidase antibodies.